Issue navigation
Volume 6, Issue Supplement_1, August 2024
2024 SNO/ASCO CNS Metastases Conference
FINAL CATEGORY: BASIC SCIENCE BRAIN METASTASES
BSBM-01 THE ROLE OF SEROTONERGIC RECEPTOR, HTR2B IN THE BRAIN METASTASIS FROM A CANCER NEUROSCIENCE PERSPECTIVE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i1, https://doi.org/10.1093/noajnl/vdae090.001
BSBM-02 SIRPΑ INTRACELLULAR SIGNALING MEDIATED MITOCHONDRIAL FISSION IN TRIPLE-NEGATIVE BREAST CANCER CELLS IS ASSOCIATED WITH BREAST-TO-BRAIN METASTASIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i1, https://doi.org/10.1093/noajnl/vdae090.002
BSBM-03 TARGETABLE GENE EXPRESSION CHANGES MEDIATE EXTRAVASATION OF BREAST CANCER CELLS FROM THE CIRCULATION AND LOCAL PROLIFERATION IN THE BRAIN
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i1, https://doi.org/10.1093/noajnl/vdae090.003
BSBM-04 THE MULTI-OMIC LANDSCAPE OF SOMATIC VARIATION ACROSS A PAN-CANCER COHORT OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i2, https://doi.org/10.1093/noajnl/vdae090.004
BSBM-06 SINGLE-CELL SPATIAL ANALYSIS OF METASTATIC BRAIN TUMORS REVEALS INTRACELLULAR BACTERIAL SIGNAL AND THEIR CORRELATION WITH THE TUMOR MICROENVIRONMENT
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i2, https://doi.org/10.1093/noajnl/vdae090.005
BSBM-08 FGFR1 PROMOTES ER+ BREAST CANCER BRAIN METASTASIS AND MODULATES INTERACTIONS WITH NEURONS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i3, https://doi.org/10.1093/noajnl/vdae090.006
BSBM-09 ASTROCYTES MEDIATE PARACRINE ACTIVATION OF FGFR1 TO ER+ BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i3, https://doi.org/10.1093/noajnl/vdae090.007
BSBM-10 GENETIC DELETION OF ERΑ OR ERΒ IN REACTIVE ASTROCYTES DECREASES REACTIVE GLIOSIS AND PROMOTES BRAIN METASTASIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i3, https://doi.org/10.1093/noajnl/vdae090.008
BSBM-11 NEUROCOGNITIVE OUTCOMES OF HIPPOCAMPUS-SPARING WHOLE-BRAIN RADIATION THERAPY VERSUS WHOLE-BRAIN RADIATION THERAPY IN PATIENTS WITH BRAIN METASTASIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i3–i4, https://doi.org/10.1093/noajnl/vdae090.009
BSBM-12 TARGETING OSIMERTINIB-RESISTANT BRAIN METASTASIS USING RAR ANTAGONISTS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i4, https://doi.org/10.1093/noajnl/vdae090.010
BSBM-13 DISTINCT UPTAKE AND ELIMINATION PROFILES FOR TRASTUZUMAB, HUMAN IGG AND BIOCYTIN-TMR IN EXPERIMENTAL HER2+ BRAIN METASTASES OF BREAST CANCER
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i4, https://doi.org/10.1093/noajnl/vdae090.011
BSBM-16 GLIOBLASTOMA AS A METASTATIC DISEASE: A POSSIBLE MOLECULAR PATHWAY OF METASTATIC SPREAD ACCORDING TO THE GENE MUTATION PROFILE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i4–i5, https://doi.org/10.1093/noajnl/vdae090.012
FINAL CATEGORY: BASIC SCIENCE LEPTOMENINGEAL DISEASE
BSLM-02 SPATIAL TRANSCRIPTOMICS ANALYSIS IDENTIFIES A UNIQUE TUMOR-PROMOTING FUNCTION OF THE MENINGEAL STROMA IN MELANOMA LEPTOMENINGEAL DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i5, https://doi.org/10.1093/noajnl/vdae090.013
BSLM-03 BRANCHED-CHAIN KETO ACIDS PROMOTE AN IMMUNE-SUPPRESSIVE AND NEURODEGENERATIVE MICROENVIRONMENT IN LEPTOMENINGEAL DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i5, https://doi.org/10.1093/noajnl/vdae090.014
BSLM-04 INTRATHECAL DELIVERY OF PEPTIDE-PULSED TYPE 1 CONVENTIONAL DENDRITIC CELL VACCINE IS HIGHLY EFFICACIOUS FOR THE TREATMENT OF BREAST CANCER-ASSOCIATED LEPTOMENINGEAL DISEASE IN PRECLINICAL MODELS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i5–i6, https://doi.org/10.1093/noajnl/vdae090.015
BSLM-05 TRASTUZUMAB DERUXTECAN IN LEPTOMENINGEAL METASTASES FROM HER2-ALTERED CANCERS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i6, https://doi.org/10.1093/noajnl/vdae090.016
BSLM-06 PROGNOSTIC SIGNIFICANCE OF CEREBROSPINAL FLUID GLUCOSE AND PROTEIN LEVELS IN METASTATIC BREAST CANCER PATIENTS WITH LEPTOMENINGEAL DISEASE: A RETROSPECTIVE STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i6, https://doi.org/10.1093/noajnl/vdae090.017
BSLM-07 A FIRST IN HUMAN PHASE 1 TRIAL OF DOSE ESCALATING INTRATHECAL (IT) DENDRITIC CELLS (CDC1S) PRIMED AGAINST HER2/HER3 IN PATIENTS (PTS) WITH LEPTOMENINGEAL DISEASE (LMD) FROM TRIPLE NEGATIVE (TNBC) OR HER2+ BREAST CANCER (BC)
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i6, https://doi.org/10.1093/noajnl/vdae090.018
BSLM-09 IDENTIFICATION OF DRUGS WITH SELECTIVE ACTIVITY AGAINST MELANOMA-ASSOCIATED LEPTOMENINGEAL DISEASE USING PATIENT-DERIVED CIRCULATING TUMOR CELLS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i7, https://doi.org/10.1093/noajnl/vdae090.019
BSLM-10 MOLECULAR AND HISTOLOGICAL CHARACTERIZATION OF NSCLC PROGRESSION TO LEPTOMENINGEAL METASTASIS WITH COMORBID INTRAPARENCHYMAL DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i7, https://doi.org/10.1093/noajnl/vdae090.020
BSLM-11 ESTABLISHING AND VALIDATING IN VIVO MODELS FOR LEPTOMENINGEAL METASTASES IN BREAST CANCER: INSIGHTS AND THERAPEUTIC IMPLICATIONS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i7, https://doi.org/10.1093/noajnl/vdae090.021
BSLM-12 IDENTIFICATION OF THE GDNF: NCAM SIGNALING AXIS AS A NOVEL TARGET AGAINST BREAST CANCER LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i7–i8, https://doi.org/10.1093/noajnl/vdae090.022
BSLM-13 EXTRACTION AND WHOLE TRANSCRIPTOME SEQUENCING OF CELL FREE RNA FROM HUMAN CEREBROSPINAL FLUID: A METHOD TO IDENTIFY BIOMARKERS OF BRAIN HEALTH AND DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i8, https://doi.org/10.1093/noajnl/vdae090.023
FINAL CATEGORY: BIOMARKERS
BMRK-01 EXTERNALLY VALIDATED PREDICTIVE NOMOGRAM FOR BRAIN METASTASIS IN EARLY-STAGE BREAST CANCER
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i8, https://doi.org/10.1093/noajnl/vdae090.024
BMRK-02 PROGNOSTIC VALUE OF CEREBROSPINAL FLUID TUMOR CELL COUNT IN LEPTOMENINGEAL DISEASE FROM SOLID TUMORS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i8, https://doi.org/10.1093/noajnl/vdae090.025
BMRK-04 EFFECT OF PRIMARY CANCER SITE AND EXTRACRANIAL PROGRESSION ON DEVELOPMENT OF BRAIN METASTASES IN PATIENTS TREATED WITH STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC SOLID TUMORS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i9, https://doi.org/10.1093/noajnl/vdae090.026
BMRK-05 ASSOCIATION BETWEEN HER2-LOW STATUS AND TIME TO DEVELOPMENT OF BRAIN METASTASES AMONG PATIENTS WITH BREAST CANCER: A RETROSPECTIVE COHORT STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i9, https://doi.org/10.1093/noajnl/vdae090.027
BMRK-06 BRAIN METASTASIS FREE SURVIVAL OF HER2 LOW AND HER2 ZERO TRIPLE NEGATIVE METASTATIC BREAST CANCER: A WILMOT CANCER INSTITUTE EXPERIENCE (THE HERZELO-TNBC STUDY)
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i9, https://doi.org/10.1093/noajnl/vdae090.028
BMRK-08 TRENDS IN BREAST CANCER BRAIN METASTASES INCIDENCE AND MORTALITY: DISPARITIES BY MOLECULAR SUBTYPES, AGE, AND RACE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i9–i10, https://doi.org/10.1093/noajnl/vdae090.029
BMRK-09 PROGNOSTIC ROLE OF TUMOR-INFILTRATING LYMPHOCYTES AND TERTIARY LYMPHOID STRUCTURES IN BRAIN METASTASIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i10, https://doi.org/10.1093/noajnl/vdae090.030
BMRK-11 REAL-WORLD EXPERIENCE WITH CIRCULATING TUMOR DNA IN CEREBROSPINAL FLUID IN PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i10, https://doi.org/10.1093/noajnl/vdae090.031
BMRK-12 THE CNSIDE CSF TUMOR CELL DETECTION PLATFORM IS A FEASIBLE, CLINICALLY RELEVANT AND SCALABLE PLATFORM FOR DISEASE MANAGEMENT FOR PATIENTS WITH LEPTOMENINGEAL DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i10–i11, https://doi.org/10.1093/noajnl/vdae090.032
BMRK-13 CSF TUMOR CELL (CSF-TC) DETECTION, QUANTIFICATION AND BIOMARKER ASSESSMENT HELPS IN CLINICAL MANAGEMENT OF BREAST CANCER AND NON-SMALL CELL LUNG CANCER PATIENTS HAVING LEPTOMENINGEAL DISEASE (FORESEE STUDY, NCT05414123)
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i11, https://doi.org/10.1093/noajnl/vdae090.033
FINAL CATEGORY: DATA SCIENCES/AI ADVANCES
DSAI-01 TUMOR EVOLUTION OF BRAIN-SPECIFIC TROPISM IN METASTATIC RENAL CELL CARCINOMA
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i11, https://doi.org/10.1093/noajnl/vdae090.034
DSAI-02 AN AUTOMATED TRAJECTORY OPTIMIZATION ALGORITHM FOR LASER INDUCED THERMAL THERAPY (LITT) FOR BRAIN TUMORS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i11–i12, https://doi.org/10.1093/noajnl/vdae090.035
DSAI-04 AI-DRIVEN MR IMAGE FEATURES VERSUS RANO-BM CRITERIA IN DISTINGUISHING RECURRENT BRAIN METASTASES FROM RADIATION TREATMENT EFFECT: A COMPARATIVE, MULTI-INSTITUTIONAL STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i12, https://doi.org/10.1093/noajnl/vdae090.036
DSAI-05 THE BRAIN TUMOR SEGMENTATION (BRATS-METS) CHALLENGE 2023: BRAIN METASTASIS SEGMENTATION ON PRE-TREATMENT MRI
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i12, https://doi.org/10.1093/noajnl/vdae090.037
DSAI-06 TECHNICAL AND ADMINISTRATIVE CHALLENGES FOR OPEN SCIENCE; REAL-LIFE EXPERIENCE FROM ASNR-MICCAI-BRATS-METS 2023 SEGMENTATION CHALLENGE DATASET
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i12, https://doi.org/10.1093/noajnl/vdae090.038
DSAI-07 DATA-DRIVEN MODELING OF EMERGING TRENDS AND COLLABORATIVE NETWORKS ACROSS BRAIN METASTASES RESEARCH: THE PAST DECADE OF INNOVATION
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i12–i13, https://doi.org/10.1093/noajnl/vdae090.039
DSAI-08 MIXED-EFFECTS DEEP-LEARNING BASED QUANTITATIVE RADIOMIC ANALYSIS OF LONGITUDINAL MAGNETIC RESONANCE IMAGING OF BRAIN METASTASES PREDICT PRIMARY TUMOR ORIGIN
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i13, https://doi.org/10.1093/noajnl/vdae090.040
DSAI-09 APPLYING CONSENSUS QUALITY OF CARE MEASURES FOR BRAIN METASTASES (BMETS-QC) TO PATIENT EHR DATA, A PILOT STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i13, https://doi.org/10.1093/noajnl/vdae090.041
FINAL CATEGORY: IMMUNO-ONCOLOGY APPROACHES
IMUN-03 IT-IO: INTRATHECAL ADMINISTRATION OF NIVOLUMAB AND IPILIMUMAB IN COMBINATION WITH SYSTEMIC COMBINATION OF NIVOLUMAB AND IPILIMUMAB IN PATIENTS WITH NSCLC OR MELANOMA AND NEWLY DIAGNOSED LEPTOMENINGEAL METASTASIS, A MULTICENTRIC PHASE I STUDY - PRELIMINARY DATA
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i14, https://doi.org/10.1093/noajnl/vdae090.042
IMUN-04 COMBINING CHECKPOINT BLOCKADE AND LASER ABLATION FOR PROGRESSIVE NON-SMALL CELL LUNG CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i14, https://doi.org/10.1093/noajnl/vdae090.043
IMUN-05 PHASE II STUDY OF NIVOLUMAB (NIVO) IN COMBINATION WITH RELATLIMAB (RELA) IN PATIENTS WITH ACTIVE MELANOMA BRAIN METASTASES (MBM)
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i14–i15, https://doi.org/10.1093/noajnl/vdae090.044
IMUN-07 TIMING AND OUTCOME OF BRAIN METASTASES FOLLOWING FIRST-LINE IPILIMUMAB PLUS NIVOLUMAB THERAPY FOR METASTATIC MELANOMA IN A COMMUNITY ONCOLOGY PRACTICE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i15, https://doi.org/10.1093/noajnl/vdae090.045
IMUN-08 DURABLE RESPONSE TO IPILIMUMAB-NIVOLUMAB (IPI-NIVO) IN ANTI-PD1 REFRACTORY MERKEL CELL CARCINOMA WITH LEPTOMENINGEAL DISEASE PROGRESSION
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i15, https://doi.org/10.1093/noajnl/vdae090.046
FINAL CATEGORY: MULTIMODALITY APPROACHES
MMOD-03 CRANIOTOMY RATES FOR BRAIN METASTASES AFTER INTRODUCTION OF IMMUNOTHERAPY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i15–i16, https://doi.org/10.1093/noajnl/vdae090.047
MMOD-04 LASER INTERSTITIAL THERMAL THERAPY (LITT) AND IMMUNOTHERAPY SYNERGY FOR RECURRENT BRAIN CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i16, https://doi.org/10.1093/noajnl/vdae090.048
MMOD-05 THE IMPACT OF EGFR VARIANTS ON INTRACRANIAL PROGRESSION FREE SURVIVAL AND OVERALL SURVIVAL IN NSCLC PATIENTS WITH BRAIN METASTASES UNDERGOING STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i16, https://doi.org/10.1093/noajnl/vdae090.049
MMOD-06 IMPACT OF SYSTEMIC THERAPY TIMING AFTER STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN-ONLY METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i16, https://doi.org/10.1093/noajnl/vdae090.050
MMOD-07 CONSORTIUM FOR INTRACRANIAL METASTASIS ACADEMIC RESEARCH (CIMARA): INTERNATIONAL INTERDISCIPLINARY COLLABORATIONS TO IMPROVE OUTCOMES OF PATIENTS WITH CNS METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i16–i17, https://doi.org/10.1093/noajnl/vdae090.051
MMOD-08 REAL WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH MELANOMA BRAIN METASTASIS: A SINGLE CENTER EXPERIENCE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i17, https://doi.org/10.1093/noajnl/vdae090.052
MMOD-09 PINEAL GERMINOMA RECURRENCE AND DISTANT METASTASIS IN A POST-CHEMOTHERAPY AND POST-RADIOTHERAPY ADULT FILIPINO: A CASE REPORT
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i17, https://doi.org/10.1093/noajnl/vdae090.053
MMOD-10 BRAIN METASTASIS, MENINGIOMA, AND GLIOMA: A RARE CASE OF MULTIPLE PRIMARY MALIGNANCIES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i17, https://doi.org/10.1093/noajnl/vdae090.054
MMOD-11 RADIATION NECROSIS AFTER CONCOMITANT EGFR-TKI AND RADIATION: A CASE SERIES AND CONSIDERATION FOR FUTURE PATIENTS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i17–i18, https://doi.org/10.1093/noajnl/vdae090.055
MMOD-12 PATHOLOGIC INCIDENCE OF TUMOR POSITIVITY VS ONLY NECROSIS AFTER PRIOR RADIATION IN PATIENTS UNDERGOING SURGICAL EXCISION FOR PRESUMED BRAIN METASTASIS RECURRENCE: INSIGHT FROM A PROSPECTIVE MULTICENTER REGISTRY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i18, https://doi.org/10.1093/noajnl/vdae090.056
MMOD-13 PREVALENCE, TREATMENT PATTERNS, AND SURVIVAL OUTCOMES OF PATIENTS WITH BRAIN METASTASES FROM SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY FROM 2013-2023 USING THE TRINETX ONCOLOGY DATABASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i18, https://doi.org/10.1093/noajnl/vdae090.057
MMOD-14 IMPACT OF SYSTEMIC THERAPY ACTIVITY ON BRAIN METASTASIS OUTCOMES IN A FEMALE AND HISPANIC-DOMINANT LUNG CANCER COHORT TREATED WITH STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i18–i19, https://doi.org/10.1093/noajnl/vdae090.058
MMOD-15 SURGICAL RESECTION AND STEREOTACTIC RADIOSURGERY IN COMBINATION FOR LOCAL THERAPY OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i19, https://doi.org/10.1093/noajnl/vdae090.059
MMOD-16 THE CHALLENGES IN ASSIGNING THE PRIMARY SOURCE OF METASTATIC FOCUS: PATHOLOGY POINT OF VIEW
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i19, https://doi.org/10.1093/noajnl/vdae090.060
MMOD-17 INTEGRATION OF MULTIMODAL ADVANCED MOLECULAR TESTING TO CLASSIFY METASTASES OF UNKNOWN PRIMARIES – A CASE OF A PATIENT WITH NO KNOWN MEDICAL HISTORY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i19, https://doi.org/10.1093/noajnl/vdae090.061
MMOD-18 THE IMPACT OF CONTRAST CLEARANCE ANALYSIS-GUIDED REPEAT SRS ON SURVIVAL IN PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i19–i20, https://doi.org/10.1093/noajnl/vdae090.062
FINAL CATEGORY: NEUROIMAGING/RADIOLOGIC ADVANCES
NIRL-01 DEEP LEARNING-BASED VOLUMETRIC SEGMENTATION ENABLES RESPONSE ASSESSMENT AFTER LASER INTERSTITIAL THERMAL THERAPY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i20, https://doi.org/10.1093/noajnl/vdae090.063
NIRL-03 REGRESSION ANALYSIS OF NON-CATEGORICAL IMAGING PARAMETERS IN PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i20, https://doi.org/10.1093/noajnl/vdae090.064
NIRL-04 BRAIN METASTASES DISTRIBUTION WIDTH (BMDW): A NOVEL METRIC TO PREDICT DISTANT BRAIN FAILURE FOLLOWING STEREOTACTIC RADIOSURGERY IN PATIENTS WITH MULTIPLE BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i20–i21, https://doi.org/10.1093/noajnl/vdae090.065
NIRL-05 DIFFERENTIATING RADIATION NECROSIS FROM TUMOR RECURRENCE IN BRAIN METASTASIS USING MRF– A FEASIBILITY STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i21, https://doi.org/10.1093/noajnl/vdae090.066
NIRL-06 IS THE PRESENCE OF NEOPLASTIC MENINGITIS ASSOCIATED WITH A WORSE PROGNOSIS IN REAL-WORLD PATIENTS WITH BREAST CANCER AND BRAIN METASTASES?
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i21, https://doi.org/10.1093/noajnl/vdae090.067
NIRL-07 DIAGNOSTIC AMBIGUITIES IN MRI CHANGES IN A PATIENT WITH BRAIN METASTASES AND RECURRENT STROKES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i21, https://doi.org/10.1093/noajnl/vdae090.068
NIRL-08 AUTOMATED LONGITUDINAL TRACKING OF BRAIN METASTASES INTEGRATED IN A USER-ORIENTED SOFTWARE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i21, https://doi.org/10.1093/noajnl/vdae090.069
NIRL-09 PERI-AMPULLARY CARCINOMA METASTASIS TO THE BRAIN: A RARE CASE REPORT FROM INDIA
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i21–i22, https://doi.org/10.1093/noajnl/vdae090.070
NIRL-10 LEPTOMENINGEAL ENHANCEMENT WITH PARANEOPLASTIC CEREBELLAR DEGENERATION: AUTOIMMUNE OR METASTASES?
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i22, https://doi.org/10.1093/noajnl/vdae090.071
NIRL-11 3D-FSE IMAGING FOR RADIOSURGERY PLANNING IMPROVES BRAIN METASTASIS DETECTION AND REDUCES INTRACRANIAL RELAPSE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i22, https://doi.org/10.1093/noajnl/vdae090.072
NIRL-12 UNDERSTANDING LESION RESPONSE ON MRI AFTER LASER INTERSTITIAL THERMAL THERAPY (LITT) IN METASTATIC BRAIN TUMOR PATIENTS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i22, https://doi.org/10.1093/noajnl/vdae090.073
NIRL-13 HISTOPATHOLOGIC CONFIRMATION OF TUMOR RECURRENCE IDENTIFIED ON CONTRAST CLEARANCE ANALYSIS MAPS - A VALIDATION STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i22–i23, https://doi.org/10.1093/noajnl/vdae090.074
NIRL-14 RADIOGRAPHIC STUDIES ON THE THRESHOLD OF HUMAN CAPACITY IN EARLY DETECTION OF SMALL BRAIN METASTASES ESTABLISH A BASIS FOR DEVELOPING ARTIFICIAL INTELLIGENCE RECOGNITION TECHNOLOGY IN BRAIN MRI
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i23, https://doi.org/10.1093/noajnl/vdae090.075
FINAL CATEGORY: NOVEL TARGETS IN CNS METASTASES (NON-IMMUNOLOGIC)
NVTG-02 CIRCULAR RNAS AS NOVEL TARGETS IN BREAST-TO-BRAIN CANCER METASTASIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i23, https://doi.org/10.1093/noajnl/vdae090.076
NVTG-03 IDENTIFYING THE DRIVERS OF EARLY BRAIN METASTASES ESTABLISHMENT IN BREAST CANCER PATIENTS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i24, https://doi.org/10.1093/noajnl/vdae090.077
NVTG-04 REAL-WORLD OUTCOMES WITH SACITUZUMAB GOVITECAN AMONG BREAST CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i24, https://doi.org/10.1093/noajnl/vdae090.078
NVTG-05 LONGITUDINAL OBSERVATION OF THE TREATMENT RESPONSE TO INTRATHECAL CHEMOTHERAPY WITH PEMETREXED VIA CIRCULATING TUMOR DNA FROM CEREBROSPINAL FLUID OF NON-SMALL CELL LUNG CANCER LEPTOMENINGEAL METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i24, https://doi.org/10.1093/noajnl/vdae090.079
NVTG-06 MELANOMA BRAIN METASTASES BENEFIT FROM HIGH PRKCZ LEVELS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i24–i25, https://doi.org/10.1093/noajnl/vdae090.080
NVTG-07 SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF TRASTUZUMAB DERUXTECAN (T-DXD) IN PATIENTS WITH HER2+ METASTATIC BREAST CANCER (MBC) AND ACTIVE BRAIN METASTASES (BMS) IN DESTINY-BREAST07 (DB-07)
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i25, https://doi.org/10.1093/noajnl/vdae090.081
NVTG-08 PERSONALIZED TREATMENT OF MELANOMA BRAIN METASTASES THROUGH HIGH THROUGHPUT DRUG SCREENING
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i25, https://doi.org/10.1093/noajnl/vdae090.082
NVTG-09 TARGETING TRKB IN LUNG-TO-BRAIN METASTATIC PROGRESSION
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i25, https://doi.org/10.1093/noajnl/vdae090.083
NVTG-10 CLINICAL AND RADIOLOGICAL OUTCOMES OF ORBITAL METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY: A SINGLE INSTITUTION RETROSPECTIVE SERIES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i25–i26, https://doi.org/10.1093/noajnl/vdae090.084
NVTG-11 EFFICACY OF TRASTUZUMAB DERUXTECAN IN HER2-POSITIVE AND HER2-LOW BREAST CANCER WITH ACTIVE BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i26, https://doi.org/10.1093/noajnl/vdae090.085
FINAL CATEGORY: ONGOING CLINICAL TRIALS
OCTS-01 DOSE ESCALATION FOR PREOPERATIVE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH LARGE BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i26, https://doi.org/10.1093/noajnl/vdae090.086
OCTS-02 ETOP 19-21 USZ-STRIKE: IMMUNOTHERAPY OR TARGETED THERAPY WITH OR WITHOUT STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH BRAIN METASTASES FROM MELANOMA OR NON-SMALL CELL LUNG CANCER
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i26, https://doi.org/10.1093/noajnl/vdae090.087
OCTS-03 A MULTICENTER, OPEN-LABEL, SINGLE-ARM, MULTICOHORT PHASE II CLINICAL TRIAL OF TRASTUZUMAB DERUXTECAN IN HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-POSITIVE AND HER2-LOW ADVANCED BREAST CANCER (ABC) WITH BRAIN METASTASES AND/OR LEPTOMENINGEAL CARCINOMATOSIS (LMC) – THE DEBBRAH STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i26–i27, https://doi.org/10.1093/noajnl/vdae090.088
OCTS-04 TRIAL IN PROGRESS: PHASE II STUDY OF PRE-OPERATIVE HYPOFRACTIONATED STEREOTACTIC RADIOSURGERY FOR RESECTABLE BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i27, https://doi.org/10.1093/noajnl/vdae090.089
OCTS-05 BRAIN BIOMARKER ANALYSIS OF LIKELY TUMOR ORIGIN (BALTO)- A PROSPECTIVE STUDY FOR THE DETECTION/DIAGNOSIS OF CNS TUMORS FROM CSF USING THE BELAY SUMMIT™ ASSAY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i27, https://doi.org/10.1093/noajnl/vdae090.090
OCTS-06 A PHASE II STUDY OF NIVOLUMAB WITH IPILIMUMAB AND CABOZANTINIB IN PATIENTS WITH UNTREATED RENAL CELL CARCINOMA BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i27–i28, https://doi.org/10.1093/noajnl/vdae090.091
OCTS-07 TRIAL IN PROGRESS: PHASE II STUDY OF RADIATION THERAPY FOLLOWED BY INTRATHECAL TRASTUZUMAB/PERTUZUMAB IN THE MANAGEMENT OF HER2+ BREAST LEPTOMENINGEAL DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i28, https://doi.org/10.1093/noajnl/vdae090.092
OCTS-08 MRI SCREENING FOR BRAIN METASTASES AMONG PATIENTS WITH TRIPLE NEGATIVE OR HER2+ STAGE II OR III BREAST CANCER: A MULTI-CENTRE, SINGLE ARM PHASE II CLINICAL TRIAL – THE INSIGHT TRIAL
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i28, https://doi.org/10.1093/noajnl/vdae090.093
OCTS-09 THE PROSPECTIVE PHASE II COG-SRS TRIAL: AN UPDATE ON COGNITIVE-SPARING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i28, https://doi.org/10.1093/noajnl/vdae090.094
OCTS-10 PREOPERATIVE TUCATINIB IN PATIENTS WITH HER2 AMPLIFIED/MUTANT BREAST OR OTHER SOLID TUMORS WHO REQUIRE BRAIN METASTASIS RESECTION: A WINDOW OF OPPORTUNITY STUDY (WINHER2 STUDY, NCT05892068)
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i28–i29, https://doi.org/10.1093/noajnl/vdae090.095
OCTS-11 PHASE 1 DOSE ESCALATION OF RHENIUM (186RE) OBISBEMEDA (RHENIUM NANOLIPOSOME,186RNL FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM): ONGOING CLINICAL STUDY UPDATE FOR INITIAL SAFETY AND FEASIBILITY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i29, https://doi.org/10.1093/noajnl/vdae090.096
FINAL CATEGORY: RADIATION THERAPY ADVANCES
RADT-01 A COMPREHENSIVE REVIEW OF THE UTILITY OF BRACHYTHERAPY IN THE MANAGEMENT OF BRAIN METASTASIS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i29, https://doi.org/10.1093/noajnl/vdae090.097
RADT-02 PRE-OPERATIVE VERSUS POST-OPERATIVE FRACTIONATED STEREOTACTIC RADIOTHERAPY: A SINGLE-INSTITUTION ANALYSIS OF 534 RESECTED METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i29, https://doi.org/10.1093/noajnl/vdae090.098
RADT-03 PRE-OPERATIVE SINGLE FRACTION VERSUS FRACTIONATED STEREOTACTIC RADIOTHERAPY: A SINGLE-INSTITUTION ANALYSIS OF 299 RESECTED METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i29–i30, https://doi.org/10.1093/noajnl/vdae090.099
RADT-04 IMPROVED SURVIVAL IN PATIENTS WITH RADIONECROSIS VS. LOCAL RECURRENCE AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i30, https://doi.org/10.1093/noajnl/vdae090.100
RADT-07 IMPACT OF KEAP1/NFE2L2 VARIANTS ON LOCAL CONTROL IN NSCLC BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i30–i31, https://doi.org/10.1093/noajnl/vdae090.101
RADT-08 IMPACT OF ELEKTA LIGHTENING OPTIMIZER ON DOSIMETRIC AND CLINICAL OUTCOMES FOR INTACT LUNG AND BREAST METASTASES USING GAMMA KNIFE RADIOSURGERY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i31, https://doi.org/10.1093/noajnl/vdae090.102
RADT-11 PREDICTING BIOPSY RESULTS OF ENLARGING BRAIN METASTASES FOLLOWING STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i31–i32, https://doi.org/10.1093/noajnl/vdae090.103
RADT-12 HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY WITH REDUCED WHOLE BRAIN DOSE ENABLES IMPROVED SPARING OF HIPPOCAMPI WITHOUT INCREASED RISK OF DISTANT BRAIN FAILURE IN NON-SMALL CELL LUNG CANCER
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i32, https://doi.org/10.1093/noajnl/vdae090.104
RADT-13 STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES SECONDARY TO PERIPHERAL NEURAL CREST TUMORS: A SINGLE INSTITUTION RETROSPECTIVE EXPERIENCE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i32, https://doi.org/10.1093/noajnl/vdae090.105
RADT-14 STEREOTACTIC RADIOSURGERY AND SACITUZUMAB-GOVITECAN FOR BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i32, https://doi.org/10.1093/noajnl/vdae090.106
RADT-15 STEREOTACTIC RADIOSURGERY FOR ADENOID CYSTIC CARCINOMA BRAIN METASTASES: A SINGLE INSTITUTION RETROSPECTIVE STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i32–i33, https://doi.org/10.1093/noajnl/vdae090.107
FINAL CATEGORY: RESEARCH METHODS AND TRIAL DESIGN CONSIDERATIONS
RMTD-01 PROGNOSTIC SIGNIFICANCE OF STABLE EXTRACRANIAL DISEASE IN PATIENTS WITH INTRACRANIAL METASTATIC DISEASE: INSIGHTS FROM A RETROSPECTIVE POPULATION-BASED STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i33, https://doi.org/10.1093/noajnl/vdae090.108
RMTD-02 PRACTICE VARIATION AND IMPACT OF PRE-OPERATIVE AND POST-OPERATIVE DEXAMETHASONE ON PATIENT OUTCOME IN THE RESECTED BRAIN METASTASIS – INSIGHTS FROM THE CLINDEXMET MULTICENTER REGISTRY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i33, https://doi.org/10.1093/noajnl/vdae090.109
RMTD-03 USE OF A BRAIN-PENETRATING ANTHRACYCLINE IN ANTHRACYCLINE-SENSITIVE BRAIN METASTASES: THE PROMISE OF BERUBICIN
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i33–i34, https://doi.org/10.1093/noajnl/vdae090.110
RMTD-04 EXAMINING THE REAL-WORLD CUMULATIVE INCIDENCE OF BRAIN METASTASES IN US MEDICARE ALK+ METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) PATIENT POPULATIONS THAT ARE UNDERREPRESENTED IN RANDOMIZED CLINICAL TRIALS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i34, https://doi.org/10.1093/noajnl/vdae090.111
RMTD-05 UNRAVELLING THE LANDSCAPE OF BRAIN METASTASES ACROSS PRIMARY CANCER TYPES: A PAN-CANCER STUDY UTILIZING THE SEER DATABASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i34, https://doi.org/10.1093/noajnl/vdae090.112
RMTD-06 TREATMENT PATTERNS AND OUTCOMES OF HR+/HER2- BREAST CANCER WITH BRAIN METASTASES: A SINGLE-CENTER RETROSPECTIVE STUDY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i34, https://doi.org/10.1093/noajnl/vdae090.113
RMTD-07 LOST CHANCES: THE SYSTEMATIC EXCLUSION OF PATIENTS WITH BRAIN METASTASIS IN EARLY-PHASE ONCOLOGY TRIALS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i34–i35, https://doi.org/10.1093/noajnl/vdae090.114
RMTD-08 RADIATION ABSORBED DOSE TO SPINAL CORD: THERAPY OF LEPTOMENINGEAL METASTASES USING BETA-EMISSION RADIOPHARMACEUTICALS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i35, https://doi.org/10.1093/noajnl/vdae090.115
FINAL CATEGORY: SPINAL CORD METASTASES
SPCM-02 ASSOCIATIONS BETWEEN INTRAOPERATIVE NEUROMONITORING USAGE AND CLINICAL OUTCOMES FOR SURGERIES AMONG PRIMARY NON-MALIGNANT SPINE TUMOR PATIENTS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i35, https://doi.org/10.1093/noajnl/vdae090.116
SPCM-03 TRENDS IN INTRAOPERATIVE NEUROMONITORING USAGE IN SURGERIES FOR PATIENTS WITH DIAGNOSED PRIMARY MALIGNANT SPINE TUMORS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i35, https://doi.org/10.1093/noajnl/vdae090.117
SPCM-04 SURGICAL EXCISION OF SPINAL INTRADURAL METASTASES: A 10 YEAR INSTITUTIONAL EXPERIENCE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i35–i36, https://doi.org/10.1093/noajnl/vdae090.118
SPCM-05 SPINAL EPITHELIOD SOLITARY FIBROUS TUMOR METASTATIC TO THE 4TH VENTRICLE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i36, https://doi.org/10.1093/noajnl/vdae090.119
FINAL CATEGORY: SUPPORTIVE CARE, PALLIATIVE CARE AND QOL
QSPC-01 INVESTIGATING DISTRESS LEVELS IN PATIENTS WITH METASTATIC SPINE DISEASE UNDERGOING SURGICAL INTERVENTION
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i36, https://doi.org/10.1093/noajnl/vdae090.120
QSPC-03 PATIENT-REPORTED QUALITY OF LIFE AFTER UNDERGOING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES: A PROSPECTIVE ASSESSMENT UTILIZING A U.S. NATIONAL REGISTRY
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i37, https://doi.org/10.1093/noajnl/vdae090.121
QSPC-04 BRAIN AND SPINE METASTASIS AWARENESS: AN INTERNATIONAL CAMPAIGN TO EDUCATE PATIENTS, PROVIDERS, AND POLITICIANS AND IMPROVE OUTCOMES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i37, https://doi.org/10.1093/noajnl/vdae090.122
QSPC-06 TIME-SERIES SINGLE-CELL ANALYSES REVEAL INCESSANT REWIRING OF MICROGLIA AFTER OF CRANIAL IRRADIATION
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i37–i38, https://doi.org/10.1093/noajnl/vdae090.123
QSPC-09 FACTORS IMPACTING QUALITY OF LIFE AFTER BRAIN METASTASES DIAGNOSIS: A MIXED METHODS STUDY OF PATIENTS AND THEIR CAREGIVERS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i38, https://doi.org/10.1093/noajnl/vdae090.124
QSPC-10 DEVELOPMENT OF ISOLATED BRAIN METASTASES UNDERNEATH THE BLOCKED PORTION OF PROPHYLACTIC CRANIAL IRRADIATION FIELD IN A PATIENT WITH SMALL CELL LUNG CANCER, LEADING TO SIGNIFICANT MORBIDITY AND DEATH
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i38, https://doi.org/10.1093/noajnl/vdae090.125
QSPC-11 NEWLY DIAGNOSED BRAIN METASTASES: WHAT ARE THE CRITERIA FOR EMERGENCY ROOM EVALUATION AND HOSPITAL ADMISSION?
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i38, https://doi.org/10.1093/noajnl/vdae090.126
QSPC-12 CNS-ONLY DISEASE IS ASSOCIATED WITH LONGER SURVIVAL BUT HIGH CNS-RELATED MORTALITY IN PATIENTS WITH HER2+ BREAST CANCER
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i38–i39, https://doi.org/10.1093/noajnl/vdae090.127
FINAL CATEGORY: SURGICAL ADVANCES AND DEVICE ADVANCES
SRGD-03 PRESENTATION AND POST-OPERATIVE OUTCOMES IN DIVERSE PATIENTS RECEIVING LASER ABLATION FOR CENTRAL NERVOUS SYSTEM METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i39, https://doi.org/10.1093/noajnl/vdae090.128
SRGD-04 FUNCTIONAL OUTCOMES FOLLOWING LASER ABLATION VERSUS RESECTION OF MOTOR CORTEX METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i39, https://doi.org/10.1093/noajnl/vdae090.129
FINAL CATEGORY: TRANSLATIONAL SCIENCE
TRSC-01 STEM CELL THERAPY HAS EFFICACY FOR LEPTOMENINGEAL DISSEMINATION OF DIVERSE TYPES OF SOLID CANCERS
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i39–i40, https://doi.org/10.1093/noajnl/vdae090.130
TRSC-02 RESPONSE TO PARP INHIBITORS IN PATIENTS WITH BREAST CANCER METASTATIC TO THE CENTRAL NERVOUS SYSTEM
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i40, https://doi.org/10.1093/noajnl/vdae090.131
TRSC-04 DE NOVO GTP SYNTHESIS IS A METABOLIC VULNERABILITY FOR THE INTERCEPTION OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i40, https://doi.org/10.1093/noajnl/vdae090.132
TRSC-05 TUMOR REACTIVE T CELLS FROM THE CEREBROSPINAL FLUID IN MELANOMA LEPTOMENINGEAL DISEASE
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i40, https://doi.org/10.1093/noajnl/vdae090.133
TRSC-06 CHARACTERIZATION OF A NON-SMALL CELL LUNG CANCER ROS1-FUSION BRAIN METASTASIS MODEL
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Pages i40–i41, https://doi.org/10.1093/noajnl/vdae090.134
TRSC-07 COMBINATION OF ENDOCRINE THERAPY WITH RADIATION DECREASES BRAIN METASTASES THROUGH REACTIVATION OF EFFECTOR IMMUNE-CELL RECRUITMENT TO THE BRAIN
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i41, https://doi.org/10.1093/noajnl/vdae090.135
